RxDoctor Payments Data

Leonard Pace

Physical Medicine & Rehabilitation · Brooklyn, NYNPI 1639110620

Payments from drug & device makers

$4,701in general payments, 2019–2025

Across 224 payments — averaging $20.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$901
  • UCB, Inc.$730
  • Lilly USA, LLC$430
  • Amneal Pharmaceuticals LLC$328
  • AbbVie$327
  • Otsuka America Pharmaceutical, Inc.$307
  • plus $2K from 22 others

What the payments were for

  • Speaking & faculty fees$651%
  • Food & beverage$4,62598%
  • Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,701 in reported general payments places this provider in the 90th percentile of 872 physical medicine & rehabilitation providers in New York.

See all physical medicine & rehabilitation providers in New York

Medicare billing

Part B allowed, 2024
$506,667
Medicare patients
1,106
Services billed
4,042

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RytaryCarbidopa/Levodopa18$13,042
Memantine Hcl128$3,390
TegretolCarbamazepine13$2,124
Oxcarbazepine24$1,376
Tetrabenazine11$1,055
Divalproex Sodium33$1,043
Levetiracetam56$1,027
Carbidopa-LevodopaCarbidopa/Levodopa48$993
Gabapentin87$966
Donepezil Hcl107$767
Doxepin Hcl12$657
Ropinirole Hcl26$447
Phenobarbital12$356
Pregabalin25$354
Quetiapine Fumarate17$252

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Amneal Pharmaceuticals LLCRytary$328$13,04218 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 872 physical medicine & rehabilitation providers in New York.

Other physical medicine & rehabilitation in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →